Katherine Gotham is assistant professor of psychiatry at Vanderbilt University in Nashville, Tennessee.
Katherine Gotham
Assistant Professor of Psychiatry
Rowan University
From this contributor
Measuring alexithymia in autistic people
Despite the growing interest in alexithymia in autism research, the tools commonly used to measure this trait may not work reliably in autistic populations. A new scoring method fills that gap.
Measuring alexithymia in autistic people
Suicidal tendencies hard to spot in some people with autism
To effectively screen for suicidality in people with autism, we need to learn how to ask questions that lead to real answers.
Suicidal tendencies hard to spot in some people with autism
Understanding aggression in autism
Two new studies explore the link between autism and aggression — a controversial connection that weighs heavily on individuals with the disorder and their families.
Understanding aggression in autism
How persistent worrying might cause the blues
When individuals with autism see themselves as impaired and get stuck on those thoughts, they may become and stay depressed, says Katherine Gotham.
How persistent worrying might cause the blues
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.